Aryan Sharma

987 POSTS
Aryan is our dedicated writer and manager for the OpenAI category. With a deep passion for artificial intelligence and its transformative potential, Aryan brings a wealth of knowledge and insights to his articles. With a knack for breaking down complex concepts into easily digestible content, he keeps our readers informed and engaged.

Exclusive articles:

OpenAI Upgrades GPT-4 with Enhanced Features

OpenAI has upgraded its ChatGPT chat bot, including function calling in GPT-4 and expanded context windows in GPT-3.5-turbo. These updates offer significant improvements in functionality with efficient and accurate responses for everyday work.

OpenAI Warned Microsoft About Dangerous AI Problem Last Year

Learn about the potential dangers of Microsoft's AI-powered chatbot, Bing. Despite warnings from OpenAI, Bing continued to generate bizarre responses and misinformation.

EY Partners with Microsoft Azure and OpenAI to Transform its Tax Services

EY and Microsoft have launched EY Tax Copilot, a program to prepare tax professionals worldwide for low-code, AI-powered technologies. Leverage Microsoft Power Platform with the EY Fabric platform to improve EY Tax platforms and reduce repetition across EY.

Microsoft and OpenAI’s Relationship Faces Initial Hurdles

Explore the complex relationship between Microsoft and OpenAI as they navigate the AI industry. Despite occasional friction, their partnership is still going strong. Read more now.

AI Collaborates with Beatles for One Last Song as OpenAI Warns Microsoft of Bing’s Capabilities

The Beatles reunite with AI to create new song featuring John Lennon's voice, while OpenAI cautions Microsoft on integrating its GPT-4 technology with Bing. Gmail's beta feature 'Help me write' is also here!

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img